Magnetic seizure therapy for the treatment of depression

Advances in Biological Psychiatry

Volumn 23, Issue , 2007, Pages 155-171

  Lisanby, Sarah H ^a   Peterchev, Angel V ^a  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84870337080     PISSN: 03787354     EISSN: 16622774     Source Type: Book Series    
DOI: 10.1159/000101036     Document Type: Article

References (67)

1. American Psychiatric Association Task Force on Electroconvulsive Therapy: The Practice of Electroconvulsive Therapy: Recommendations for Treatment, Training, and Privileging. Washington, American Psychiatric Association, 2001.
2. Trivedi MH, Rush AJ, Wisniewski SR, Nierenberg AA, Warden D, Ritz L, Norquist G, Howland RH, Lebowitz B, McGrath PJ, Shores-Wilson K, Biggs MM, Balasubramani GK, Fava M: Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry 2006;163:28-40.
3. Rush AJ, Trivedi MH, Wisniewski SR, Stewart JW, Nierenberg AA, Thase ME, Ritz L, Biggs MM, Warden D, Luther JF, Shores-Wilson K, Niederehe G, Fava M: Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression. N Engl J Med 2006;354:1231-1242.
4. Sackeim H: Magnetic stimulation therapy and ECT. Convuls Ther 1994;10:255-258.
5. Lisanby SH, Luber B, Finck AD, Schroeder C, Sackeim HA: Deliberate seizure induction with repetitive transcranial magnetic stimulation in nonhuman primates. Arch Gen Psychiatry 2001;58: 199-200 (erratum 515).
6. Lisanby SH: Magnetic seizure therapy: development of a novel convulsive technique; in Lisanby SH (ed): Brain Stimulation in Psychiatric Treatment. Arlington, American Psychiatric Publishing, Inc, 2004, vol 23, chapter 4, pp 77-116.
7. Gershon AA, Dannon PN, Grunhaus L: Transcranial magnetic stimulation in the treatment of depression. Am J Psychiatry 2003;160:835-845.
8. Burt T, Lisanby SH, Sackeim HA: Neuropsychiatric applications of transcranial magnetic stimulation: a meta analysis. Int J Neuropsychopharmacol 2002;5:73-103.
9. Grunhaus L, Dannon PN, Schreiber S, Dolberg OH, Amiaz R, Ziv R, Lefkifker E: Repetitive transcranial magnetic stimulation is as effective as electroconvulsive therapy in the treatment of nondelusional major depressive disorder: an open study. Biol Psychiatry 2000;47:314-324.
10. Grunhaus L, Schreiber S, Dolberg OT, Polak D, Dannon PN: A randomized controlled comparison of electroconvulsive therapy and repetitive transcranial magnetic stimulation in severe and resistant nonpsychotic major depression. Biol Psychiatry 2003;53:324-331.
11. Janicak PG, Dowd SM, Martis B, Alam D, Beedle D, Krasuski J, Strong MJ, Sharma R, Rosen C, Viana M: Repetitive transcranial magnetic stimulation versus electroconvulsive therapy for major depression: preliminary results of a randomized trial. Biol Psychiatry 2002;51:659-667.
12. McLoughlin D, Eranti SV, Mogg A, Pluck G, Purvis R, Edwards D: A 6-month, follow-up, pragmatic randomised controlled trial of ECT and rTMS in major depression. J ECT 2005;21:59.
13. Group UER: Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis. Lancet 2003;361:799-808.
14. Prudic J, Sackeim H: Electroconvulsive therapy and suicide risk. J Clin Psychiatry 1999;60(suppl 2): 104-110.
15. Lisanby SH, Maddox JH, Prudic J, Devanand DP, Sackeim HA: The effects of electroconvulsive therapy on memory of autobiographical and public events. Arch Gen Psychiatry 2000;57: 581-590.
16. Weiner RD: Retrograde amnesia with electroconvulsive therapy: characteristics and implications. Arch Gen Psychiatry 2000;57:591-592.
17. Sobin C, Sackeim HA, Prudic J, Devanand DP, Moody BJ, McElhiney MC: Predictors of retrograde amnesia following ECT. Am J Psychiatry 1995;152:995-1001.
18. Squire LR, Slater PC, Miller PL: Retrograde amnesia and bilateral electroconvulsive therapy. Long-term follow-up. Arch Gen Psychiatry 1981;38:89-95.
19. Donahue AB: Electroconvulsive therapy and memory loss: a personal journey. J ECT 2000;16: 133-143.
20. Sackeim HA, Haskett RF, Mulsant BH, Thase ME, Mann JJ, Pettinati HM, Greenberg RM, Crowe RR, Cooper TB, Prudic J: Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial. JAMA 2001;285:1299-1307.
21. Sackeim HA, Prudic J, Devanand DP, Nobler MS, Lisanby SH, Peyser S, Fitzsimons L, Moody BJ, Clark J: A prospective, randomized, double-blind comparison of bilateral and right unilateral electroconvulsive therapy at different stimulus intensities. Arch Gen Psychiatry 2000;57:425-434.
22. Sackeim HA, Prudic J, Devanand DP, Kiersky JE, Fitzsimons L, Moody BJ, McElhiney MC, Coleman EA, Settembrino JM: Effects of stimulus intensity and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy. N Engl J Med 1993;328:839-846.
23. Sackeim HA, Portnoy S, Neeley P, Steif BL, Decina P, Malitz S: Cognitive consequences of lowdosage electroconvulsive therapy. Ann NY Acad Sci 1986;462:326-340.
24. Chen AC, Shin KH, Duman RS, Sanacora G: ECS-induced mossy fiber sprouting and BDNF expression are attenuated by ketamine pretreatment. J ECT 2001;17:27-32.
25. Gombos Z, Spiller A, Cottrell GA, Racine RJ, McIntyre Burnham W: Mossy fiber sprouting induced by repeated electroconvulsive shock seizures. Brain Res 1999;844:28-33.
26. Lisanby S, Sackeim H, Dwork AJ, Underwood M, Wang X, Kassir SA, Luber B, Arango V: Effects of electroconvulsive shock and magnetic seizure therapy on mossy fiber sprouting and cellular proliferation in the primate hippocampus. Biol Psychiatry 2003;53:173S.
27. Lipp HP, Schwegler H, Heimrich B, Driscoll P: Infrapyramidal mossy fibers and two-way avoidance learning: developmental modification of hippocampal circuitry and adult behavior of rats and mice. J Neurosci 1988;8:1905-1921.
28. Lisanby SH: Update on magnetic seizure therapy: a novel form of convulsive therapy. J ECT 2002;18:182-188.
29. Lisanby SH, Morales O, Payne N, Kwon E, Fitzsimons L, Luber B, Nobler MS, Sackeim HA: New developments in electroconvulsive therapy and magnetic seizure therapy. CNS Spectr 2003;8: 529-536.
30. Lisanby SH, Schlaepfer TE, Fisch HU, Sackeim HA: Magnetic seizure therapy of major depression. Arch Gen Psychiatry 2001;58:303-305.
31. Sackeim HA, Long J, Luber B, Moeller JR, Prohovnik I, Devanand DP, Nobler MS: Physical properties and quantification of the ECT stimulus. 1. Basic principles. Convuls Ther 1994;10:93-123.
32. Lisanby SH, Devanand DP, Nobler MS, Prudic J, Mullen L, Sackeim HA: Exceptionally high seizure threshold: ECT device limitations. Convuls Ther 1996;12:156-164.
33. Barker AT, Jalinous R, Freeston IL: Non-invasive magnetic stimulation of human motor cortex. Lancet 1985;i:1106-1107.
34. Lisanby SH, Moscrip T, Morales O, Luber B, Schroeder C, Sackeim HA: Neurophysiological characterization of magnetic seizure therapy (MST) in non-human primates. Suppl Clin Neurophysiol 2003;56:81-99.
35. White PF, Amos Q, Zhang Y, Stool L, Husain MM, Thornton L, Downing M, McClintock S, Lisanby SH: Anesthetic considerations for magnetic seizure therapy: a novel therapy for severe depression. Anesth Analg 2006;103:76-80.
36. Lisanby SH, Luber B, Schlaepfer TE, Sackeim HA: Safety and feasibility of magnetic seizure therapy (MST) in major depression: randomized within-subject comparison with electroconvulsive therapy. Neuropsychopharmacology 2003;28:1852-1865.
37. Zangen A, Roth Y, Voller B, Hallett M: Transcranial magnetic stimulation of deep brain regions: evidence for efficacy of the H-coil. Clin Neurophysiol 2005;116:775-779.
38. Roth Y, Zangen A, Hallett M: A coil design for transcranial magnetic stimulation of deep brain regions. J Clin Neurophysiol 2002;19:361-370.
39. Bohning DE, Pecheny AP, Epstein CM, Speer AM, Vincent DJ, Dannels W, George MS: Mapping transcranial magnetic stimulation (TMS) fields in vivo with MRI. Neuroreport 1997;8: 2535-2538.
40. Heller L, van Hulsteyn DB: Brain stimulation using electromagnetic sources: theoretical aspects. Biophys J 1992;63:129-138.
41. Epstein CM, Davey KR: Iron-core coils for transcranial magnetic stimulation. J Clin Neurophysiol 2002;19:376-381.
42. Wassermann EM, Cohen LG, Flitman SS, Chen R, Hallett M: Seizures in healthy people with repeated 'safe' trains of transcranial magnetic stimuli. Lancet 1996;347:825-826.
43. Pascual-Leone A, Houser CM, Reese K, Shotland LI, Grafman J, Sato S, Valls-Sole J, Brasil-Neto JP, Wassermann EM, Cohen LG: Safety of rapid-rate transcranial magnetic stimulation in normal volunteers. Electroencephalogr Clin Neurophysiol 1993;89:120-130.
44. Wassermann EM: Risk and safety of repetitive transcranial magnetic stimulation: report and suggested guidelines from the International Workshop on the Safety of Repetitive Transcranial Magnetic Stimulation, June 5-7, 1996. Electroencephalogr Clin Neurophysiol 1998;108:1-16.
45. Devanand DP, Lisanby SH, Nobler MS, Sackeim HA: The relative efficiency of altering pulse frequency or train duration when determining seizure threshold. J ECT 1998;14:227-235.
46. Kosel M, Frick C, Lisanby SH, Fisch HU, Schlaepfer TE: Magnetic seizure therapy improves mood in refractory major depression. Neuropsychopharmacology 2003;28:2045-2048.
47. Davey K, Epstein CM: Magnetic stimulation coil and circuit design. IEEE Trans Biomed Eng 2000;47:1493-1499.
48. Barker AT, Garnham CW, Freeston IL: Magnetic nerve stimulation: the effect of waveform on efficiency, determination of neural membrane time constants and the measurement of stimulator output. Electroencephalogr Clin Neurophysiol Suppl 1991;43:227-237.
49. Peterchev A, Spellman T, Lisanby SH: cTMS: a novel TMS device inducing near rectangular pulses with controllable pulse width. ACNP Annu Meet Abstr, in press.
50. Jalinous R: Principles of magnetic stimulator design; in Pascual-Leone A, Davey NJ, Rothwell J, Wassermann EM, Puri BK (eds): Handbook of Transcranial Magnetic Stimulation. London, Arnold, 2002, pp 30-38.
51. Sommer M, Alfaro A, Rummel M, Speck S, Lang N, Tings T, Paulus W: Half sine, monophasic and biphasic transcranial magnetic stimulation of the human motor cortex. Clin Neurophysiol 2006;117:838-844.
52. Tings T, Lang N, Tergau F, Paulus W, Sommer M: Orientation-specific fast rTMS maximizes corticospinal inhibition and facilitation. Exp Brain Res 2005;164:323-333.
53. Taylor JL, Loo CK: Stimulus waveform influences the efficacy of repetitive transcranial magnetic stimulation. J Affect Disord, in press.
54. Sommer M, Paulus W: Pulse configuration and rTMS efficacy: a review of clinical studies. Suppl Clin Neurophysiol 2003;56:33-41.
55. Belmaker B, Fitzgerald P, George MS, Lisanby SH, Pascual-Leone A, Schlaepfer TE, Wassermann E: Managing the risks of repetitive transcranial stimulation. CNS Spectr 2003;8:489.
56. Moscrip TD, Terrace HS, Sackeim HA, Lisanby SH: Randomized controlled trial of the cognitive side-effects of magnetic seizure therapy (MST) and electroconvulsive shock (ECS). Int J Neuropsychopharmacol 2006;9:1-11.
57. Lisanby S, Husain M, Morales O, Thornton WL, White PF, Payne N, Rush AJ, Sackeim H: Controlled clinical trial of the antidepressant efficacy of magnetic seizure therapy in the treatment of major depression. ACNP Annu Meet Abstr 2003;166.
58. Dwork AJ, Arango V, Underwood M, Ilievski B, Rosoklija G, Sackeim H, Lisanby S: Absence of histological lesions in primate models of electroconvulsive therapy (ECT) and magnetic seizure therapy (MST). Am J Psychiatry 2004;161:576-578.
59. Moscrip T, Terrace H, Sackeim H, Lisanby SH: A primate model of the anterograde and retrograde amnesia produced by convulsive treatment. J ECT 2004;20:26-36.
60. Moscrip T, Terrace H, Sackeim H, Lisanby S: A primate model of the cognitive and electrophysiological effects of electroconvulsive shock (ECS) and magnetic seizure therapy (MST). J ECT 2004;20:64.
61. Scalia J, Lisanby S, Underwood M, Sackeim H, Dwork AJ, Morales O, Fung E, Arango V: The spatial distribution of mossy fiber sprouting in a non-human primate model for electroconvulsive therapy and magnetic seizure therapy. Biol Psychiatry 2004;55:207S.
62. Morales O, Luber B, Kwon E, Ellsasser R, Sackeim HA, Lisanby SH: Prolactin response to convulsive therapy: magnetic seizure therapy (MST) versus electroconvulsive shock (ECS) in nonhuman primates. J ECT 2003;19:58A.
63. Lisanby SH, Pakkenberg B, Dwork AJ, Christensen JR, Larsen KB, Scalia J, Underwood M, Sackeim HA, Arango V: Stereological and neuropathological examination of the safety of electroconvulsive shock (ECS) and magnetic seizure therapy (MST) in nonhuman primates. Biol Psychiatry 2005;57:147S.
64. Perera TD, Luber B, Nobler MS, Prudic J, Anderson C, Sackeim HA: Seizure expression during electroconvulsive therapy: relationships with clinical outcome and cognitive side effects. Neuropsychopharmacology 2004;29:813-825.
65. Lisanby S, Moscrip T, Luber B, Truesdale M, Reyes N, Trottmann L, Terrace HS: Randomized controlled trial of the cognitive side effects of magnetic seizure therapy and electroconvulsive shock. ACNP Annu Meet Abstr 2005;30:178S.
66. Iyer MB, Schleper N, Wassermann EM: Priming stimulation enhances the depressant effect of low-frequency repetitive transcranial magnetic stimulation. J Neurosci 2003;23:10867-10872.
67. Huang YZ, Edwards MJ, Rounis E, Bhatia KP, Rothwell JC: Theta burst stimulation of the human motor cortex. Neuron 2005;45:201-206.